Assessment and treatment of stroke in children

Article

Opinion statement

Pediatric stroke remains underrecognized by physicians and families despite efforts to increase awareness. Although the incidence is only 2 to 3 per 100,000 children, stroke is a significant cause of disability in childhood. Ischemic and hemorrhagic strokes occur with approximately equal frequency. How these children should be evaluated and treated has not been well studied, except for randomized, controlled trials performed in children with sickle cell disease. There are consensus guidelines for the evaluation and treatment of ischemic stroke in children but not for hemorrhagic stroke. Extrapolation from the adult stroke literature is problematic in some cases. Children should be evaluated urgently and thoroughly, as multiple stroke risk factors may be present. Treatment includes supportive care geared to reducing metabolic demands in the setting of cerebral ischemia or hemorrhage, as well as targeted therapy depending on the presumed cause of stroke and individual patient risk factors.

References and Recommended Reading

  1. 1.
    Lynch JK, Hirtz DG, DeVeber G, et al.: Report of the National Institute of Neurological Disorders and Stroke workshop on perinatal and childhood stroke. Pediatrics 2002, 109:116–123.PubMedCrossRefGoogle Scholar
  2. 2.
    Anderson RN, Smith BL: Deaths: leading causes for 2002. Natl Vital Stat Rep 2005, 53:17–18.Google Scholar
  3. 3.
    Heideman RL, Packer RJ, Albright LA, et al.: Tumors of the central nervous system. In Principles and Practice of Pediatric Oncology, edn 3. Edited by Pizzo PA, Paplack DG. Philadelphia: Lippincott; 1997: 633–697.Google Scholar
  4. 4.
    Blom I, De Schryver EL, Kappelle LJ, et al.: Prognosis of haemorrhagic stroke in childhood: a long-term follow-up study. Dev Med Child Neurol 2003, 45:233–239.PubMedCrossRefGoogle Scholar
  5. 5.
    Lynch JK, Han CJ: Pediatric stroke: what do we know and what do we need to know? Semin Neurol 2005, 25:410–423.PubMedCrossRefGoogle Scholar
  6. 6.
    Paediatric Stroke Working Group: Stroke in childhood: clinical guidelines for diagnosis, management and rehabilitation. London: Royal College of Physicians of London; 2004. Available at http://www.rcplondon.ac.uk/pubs/books/childstroke/childstroke_guidelines.pdf. Accessed May 30, 2008.Google Scholar
  7. 7.
    Monagle P, Chan A, Massicotte P, et al.: Antithrombotic therapy in children: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004, 126:645S–687S.PubMedCrossRefGoogle Scholar
  8. 8.
    Fullerton HJ, Wu YW, Zhao S, et al.: Risk of stroke in children: ethnic and gender disparities. Neurology 2003, 61:189–194.PubMedGoogle Scholar
  9. 9.
    Broderick J, Talbot GT, Prenger E, et al.: Stroke in children within a major metropolitan area: the surprising importance of intracerebral hemorrhage. J Child Neurol 1993, 8:250–255.PubMedGoogle Scholar
  10. 10.
    Broderick J, Connolly S, Feldmann E, et al.: Guidelines for the management of spontaneous intracerebral hemorrhage in adults: 2007 update: a guideline from the American Heart Association/American Stroke Association Stroke Council, High Blood Pressure Research Council, and the Quality of Care and Outcomes in Research Interdisciplinary Working Group. Circulation 2007, 116:e391–e413.PubMedCrossRefGoogle Scholar
  11. 11.
    Fullerton HJ, Wu YW, Sidney S, et al.: Risk of recurrent childhood arterial ischemic stroke in a population-based cohort: the importance of cerebrovascular imaging. Pediatrics 2007, 119:495–501.PubMedCrossRefGoogle Scholar
  12. 12.
    Fullerton HJ, Wu YW, Sidney S, et al.: Recurrent hemorrhagic stroke in children: a population-based cohort study. Stroke 2007, 38:2658–2662.PubMedCrossRefGoogle Scholar
  13. 13.
    Jordan LC, Johnston SC, Wu YW, et al.: The importance of cerebral aneurysms in childhood hemorrhagic stroke: a population-based study. Stroke 2008 (in press).Google Scholar
  14. 14.
    Ganesan V, Prengler M, McShane MA, et al.: Investigation of risk factors in children with arterial ischemic stroke. Ann Neurol 2003, 53:167–173.PubMedCrossRefGoogle Scholar
  15. 15.
    Bernard TJ, Goldenberg NA: Pediatric arterial ischemic stroke. Pediatr Clin North Am 2008, 55:323–338.PubMedCrossRefGoogle Scholar
  16. 16.
    Carvalho KS, Garg BP: Arterial strokes in children. Neurol Clin 2002, 20:1079–1100.PubMedCrossRefGoogle Scholar
  17. 17.
    Nowak-Gottl U, Strater R, Heinecke A, et al.: Lipoprotein (a) and genetic polymorphisms of clotting factor V, prothrombin, and methylenetetrahydrofolate reductase are risk factors of spontaneous ischemic stroke in childhood. Blood 1999, 94:3678–3682.PubMedGoogle Scholar
  18. 18.
    Strater R, Vielhaber H, Kassenbohmer R, et al.: Genetic risk factors of thrombophilia in ischaemic childhood stroke of cardiac origin. A prospective ESPED survey. Eur J Pediatr 1999, 158(Suppl 3):S122–S125.PubMedCrossRefGoogle Scholar
  19. 19.
    deVeber G, Roach ES, Riela AR, et al.: Stroke in children: recognition, treatment, and future directions. Semin Pediatr Neurol 2000, 7:309–317.PubMedCrossRefGoogle Scholar
  20. 20.
    Jordan LC, Jallo GI, Gailloud P: Recurrent intracerebral hemorrhage from a cerebral arteriovenous malformation undetected by repeated noninvasive neuroimaging in a 4-year-old boy. J Neurosurg Pediatrics 2008, 1:316–319.PubMedCrossRefGoogle Scholar
  21. 21.
    Mayberg MR, Batjer HH, Dacey R, et al.: Guidelines for the management of aneurysmal subarachnoid hemorrhage. A statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Stroke 1994, 25:2315–2328.PubMedGoogle Scholar
  22. 22.
    Turjman F, Massoud TF, Vinuela F, et al.: Correlation of the angioarchitectural features of cerebral arteriovenous malformations with clinical presentation of hemorrhage. Neurosurgery 1995, 37:856–860; discussion 860–862.PubMedCrossRefGoogle Scholar
  23. 23.
    deVeber G: In pursuit of evidence-based treatments for paediatric stroke: the UK and Chest guidelines. Lancet Neurol 2005, 4:432–436.PubMedCrossRefGoogle Scholar
  24. 24.
    Adams HP Jr, del Zoppo G, Alberts MJ, et al.: Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups. Stroke 2007, 38:1655–1711.PubMedCrossRefGoogle Scholar
  25. 25.
    Lusher JM, Haghighat H, Khalifa AS: A prophylactic transfusion program for children with sickle cell anemia complicated by CNS infarction. Am J Hematol 1976, 1:265–273.PubMedCrossRefGoogle Scholar
  26. 26.
    Adams RJ, McKie VC, Hsu L, et al.: Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography. N Engl J Med 1998, 339:5–11.PubMedCrossRefGoogle Scholar
  27. 27.
    Fullerton HJ, Adams RJ, Zhao S, et al.: Declining stroke rates in Californian children with sickle cell disease. Blood 2004, 104:336–339.PubMedCrossRefGoogle Scholar
  28. 28.
    Atweh GF, DeSimone J, Saunthararajah Y, et al.: Hemoglobinopathies. Hematology Am Soc Hematol Educ Program 2003: 14–39.Google Scholar
  29. 29.
    Wayne AS, Schoenike SE, Pegelow CH: Financial analysis of chronic transfusion for stroke prevention in sickle cell disease. Blood 2000, 96:2369–2372.PubMedGoogle Scholar
  30. 30.
    Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. N Engl J Med 1995, 333:1581–1587.Google Scholar
  31. 31.
    Gabis LV, Yangala R, Lenn NJ: Time lag to diagnosis of stroke in children. Pediatrics 2002, 110:924–928.PubMedCrossRefGoogle Scholar
  32. 32.
    Carlson MD, Leber S, Deveikis J, et al.: Successful use of rt-PA in pediatric stroke. Neurology 2001, 57:157–158.PubMedGoogle Scholar
  33. 33.
    Benedict SL, Ni OK, Schloesser P, et al.: Intra-arterial thrombolysis in a 2-year-old with cardioembolic stroke. J Child Neurol 2007, 22:225–227.PubMedCrossRefGoogle Scholar
  34. 34.
    Janjua N, Nasar A, Lynch JK, et al.: Thrombolysis for ischemic stroke in children: data from the nationwide inpatient sample. Stroke 2007, 38:1850–1854.PubMedCrossRefGoogle Scholar
  35. 35.
    Grigoriadis S, Gomori JM, Grigoriadis N, et al.: Clinically successful late recanalization of basilar artery occlusion in childhood: what are the odds? Case report and review of the literature. J Neurol Sci 2007, 260:256–260.PubMedCrossRefGoogle Scholar
  36. 36.
    Monagle P, Barnes C, Ignjatovic V, et al.: Developmental haemostasis. Impact for clinical haemostasis laboratories. Thromb Haemost 2006, 95:362–372.PubMedGoogle Scholar
  37. 37.
    Golomb MR, Rafay M, Armstrong D, et al.: Intra-arterial tissue plasminogen activator for thrombosis complicating cerebral angiography in a 17-year-old girl. J Child Neurol 2003, 18:420–423.PubMedCrossRefGoogle Scholar
  38. 38.
    Kirton A, Wong JH, Mah J, et al.: Successful endovascular therapy for acute basilar thrombosis in an adolescent. Pediatrics 2003, 112:e248–e251.PubMedCrossRefGoogle Scholar
  39. 39.
    Schror K: Aspirin and Reye syndrome: a review of the evidence. Paediatr Drugs 2007, 9:195–204.PubMedCrossRefGoogle Scholar
  40. 40.
    American Academy of Pediatrics Committee on Infectious Diseases: Prevention of influenza: recommendations for influenza immunization of children, 2007–2008. Pediatrics 2008, 121:e1016–e1031.CrossRefGoogle Scholar
  41. 41.
    Soman T, Rafay MF, Hune S, et al.: The risks and safety of clopidogrel in pediatric arterial ischemic stroke. Stroke 2006, 37:1120–1122.PubMedCrossRefGoogle Scholar
  42. 42.
    Strater R, Kurnik K, Heller C, et al.: Aspirin versus low-dose low-molecular-weight heparin: antithrombotic therapy in pediatric ischemic stroke patients: a prospective follow-up study. Stroke 2001, 32:2554–2558.PubMedCrossRefGoogle Scholar
  43. 43.
    Hedner U: Recombinant coagulation factor VIIa: from the concept to clinical application in hemophilia treatment in 2000. Semin Thromb Hemost 2000, 26:363–366.PubMedCrossRefGoogle Scholar
  44. 44.
    O’Connell KA, Wood JJ, Wise RP, et al.: Thromboembolic adverse events after use of recombinant human coagulation factor VIIa. JAMA 2006, 295:293–298.PubMedCrossRefGoogle Scholar
  45. 45.
    Mayer SA, Brun NC, Begtrup K, et al.: Recombinant activated factor VII for acute intracerebral hemorrhage. N Engl J Med 2005, 352:777–785.PubMedCrossRefGoogle Scholar
  46. 46.
    Mayer SA, FAST Trial Steering Committee: Complications in patients with intracerebral hemorrhage treated with recombinant factor VIIa. Neurology 2007, 69:319–320.CrossRefGoogle Scholar
  47. 47.
    Kissela BM, Eckman MH: Cost effectiveness of recombinant factor VIIa for treatment of intracerebral hemorrhage. BMC Neurol 2008, 8:17.PubMedCrossRefGoogle Scholar
  48. 48.
    Ruf B, Heckmann M, Schroth I, et al.: Early decompressive craniectomy and duraplasty for refractory intracranial hypertension in children: results of a pilot study. Crit Care 2003, 7:R133–R138.PubMedCrossRefGoogle Scholar
  49. 49.
    Robertson SC, Lennarson P, Hasan DM, et al.: Clinical course and surgical management of massive cerebral infarction. Neurosurgery 2004, 55:55–61.PubMedCrossRefGoogle Scholar
  50. 50.
    Vahedi K, Hofmeijer J, Juettler E, et al.: Early decompressive surgery in malignant infarction of the middle cerebral artery: a pooled analysis of three randomised controlled trials. Lancet Neurol 2007, 6:215–222.PubMedCrossRefGoogle Scholar
  51. 51.
    Mendelow AD, Gregson BA, Fernandes HM, et al.: Early surgery versus initial conservative treatment in patients with spontaneous supratentorial intracerebral haematomas in the International Surgical Trial in Intracerebral Haemorrhage (STICH): a randomised trial. Lancet 2005, 365:387–397.PubMedGoogle Scholar
  52. 52.
    Rabinstein AA, Atkinson JL, Wijdicks EF: Emergency craniotomy in patients worsening due to expanded cerebral hematoma: to what purpose? Neurology 2002, 58:1367–1372.PubMedGoogle Scholar
  53. 53.
    Broderick JP, Diringer MN, Hill MD, et al.: Determinants of intracerebral hemorrhage growth: an exploratory analysis. Stroke 2007, 38:1072–1075.PubMedCrossRefGoogle Scholar
  54. 54.
    Mathew P, Teasdale G, Bannan A, et al.: Neurosurgical management of cerebellar haematoma and infarct. J Neurol Neurosurg Psychiatry 1995, 59:287–292.PubMedCrossRefGoogle Scholar
  55. 55.
    Fung LW, Thompson D, Ganesan V: Revascularisation surgery for paediatric moyamoya: a review of the literature. Childs Nerv Syst 2005, 21:358–364.PubMedCrossRefGoogle Scholar
  56. 56.
    Scott RM, Smith JL, Robertson RL, et al.: Long-term outcome in children with moyamoya syndrome after cranial revascularization by pial synangiosis. J Neurosurg 2004, 100:142–149.PubMedGoogle Scholar
  57. 57.
    Ikezaki K: Rational approach to treatment of moyamoya disease in childhood. J Child Neurol 2000, 15:350–356.PubMedCrossRefGoogle Scholar
  58. 58.
    Scott RM: Surgery for moyamoya syndrome? Yes. Arch Neurol 2001, 58:128–129.PubMedCrossRefGoogle Scholar
  59. 59.
    Hosain SA, Hughes JT, Forem SL, et al.: Use of a calcium channel blocker (nicardipine HCl) in the treatment of childhood moyamoya disease. J Child Neurol 1994, 9:378–380.PubMedGoogle Scholar
  60. 60.
    Calamante F, Ganesan V, Kirkham FJ, et al.: MR perfusion imaging in moyamoya syndrome: potential implications for clinical evaluation of occlusive cerebrovascular disease. Stroke 2001, 32:2810–2816.PubMedCrossRefGoogle Scholar
  61. 61.
    Smith ER, Butler WE, Ogilvy CS: Surgical approaches to vascular anomalies of the child’s brain. Curr Opin Neurol 2002, 15:165–171.PubMedCrossRefGoogle Scholar
  62. 62.
    Clatterbuck RE, Hsu FP, Spetzler RF: Supratentorial arteriovenous malformations. Neurosurgery 2005, 57:164–167.PubMedCrossRefGoogle Scholar
  63. 63.
    Shin M, Kawamoto S, Kurita H, et al.: Retrospective analysis of a 10-year experience of stereotactic radio surgery for arteriovenous malformations in children and adolescents. J Neurosurg 2002, 97:779–784.PubMedGoogle Scholar
  64. 64.
    Maruyama K, Kawahara N, Shin M, et al.: The risk of hemorrhage after radiosurgery for cerebral arteriovenous malformations. N Engl J Med 2005, 352:146–153.PubMedCrossRefGoogle Scholar
  65. 65.
    Levy EI, Niranjan A, Thompson TP, et al.: Radiosurgery for childhood intracranial arteriovenous malformations. Neurosurgery 2000, 47:834–841; discussion 841–842.PubMedCrossRefGoogle Scholar
  66. 66.
    Cohen-Gadol AA, Pollock BE: Radiosurgery for arteriovenous malformations in children. J Neurosurg 2006, 104:388–391.PubMedGoogle Scholar
  67. 67.
    Choi JH, Mast H, Sciacca RR, et al.: Clinical outcome after first and recurrent hemorrhage in patients with untreated brain arteriovenous malformation. Stroke 2006, 37:1243–1247.PubMedCrossRefGoogle Scholar
  68. 68.
    Stapf C, Mast H, Sciacca RR, et al.: The New York Islands AVM Study: design, study progress, and initial results. Stroke 2003, 34:e29–e33.PubMedCrossRefGoogle Scholar
  69. 69.
    Fults D, Kelly DL Jr: Natural history of arteriovenous malformations of the brain: a clinical study. Neurosurgery 1984, 15:658–662.PubMedCrossRefGoogle Scholar
  70. 70.
    Stapf C, Mohr JP: Unruptured brain arteriovenous malformations should be treated conservatively: yes. Stroke 2007, 38:3308–3309.PubMedCrossRefGoogle Scholar
  71. 71.
    Cockroft KM: Unruptured brain arteriovenous malformations should be treated conservatively: no. Stroke 2007, 38:3310–3311.PubMedCrossRefGoogle Scholar
  72. 72.
    Hartmann A, Mast H, Choi JH, et al.: Treatment of arteriovenous malformations of the brain. Curr Neurol Neurosci Rep 2007, 7:28–34.PubMedCrossRefGoogle Scholar
  73. 73.
    Wedderburn CJ, van Beijnum J, Bhattacharya JJ, et al.: Outcome after interventional or conservative management of unruptured brain arteriovenous malformations: a prospective, population-based cohort study. Lancet Neurol 2008, 7:223–230.PubMedCrossRefGoogle Scholar
  74. 74.
    Stapf C, Mast H, Sciacca RR, et al.: Predictors of hemorrhage in patients with untreated brain arteriovenous malformation. Neurology 2006, 66:1350–1355.PubMedCrossRefGoogle Scholar
  75. 75.
    Taub E, Ramey SL, DeLuca S, et al.: Efficacy of constraint-induced movement therapy for children with cerebral palsy with asymmetric motor impairment. Pediatrics 2004, 113:305–312.PubMedCrossRefGoogle Scholar
  76. 76.
    Deluca SC, Echols K, Law CR, et al.: Intensive pediatric constraint-induced therapy for children with cerebral palsy: randomized, controlled, crossover trial. J Child Neurol 2006, 21:931–938.PubMedCrossRefGoogle Scholar
  77. 77.
    Wolf SL, Winstein CJ, Miller JP, et al.: Effect of constraintinduced movement therapy on upper extremity function 3 to 9 months after stroke: the EXCITE randomized clinical trial. JAMA 2006, 296:2095–2104.PubMedCrossRefGoogle Scholar
  78. 78.
    Gordon A, Connelly A, Neville B, et al.: Modified constraint-induced movement therapy after childhood stroke. Dev Med Child Neurol 2007, 49:23–27.PubMedCrossRefGoogle Scholar
  79. 79.
    Kirton A, Chen R, Friefeld S, et al.: Contralesional repetitive transcranial magnetic stimulation for chronic hemiparesis in subcortical paediatric stroke: a randomised trial. Lancet Neurol 2008, 7:507–513.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2008

Authors and Affiliations

  1. 1.Johns Hopkins University School of MedicineBaltimoreUSA

Personalised recommendations